EUVIMEDEUVIMED entdecken
Crossref

Evaluation of the Diagnostic Importance of Laboratory Markers in Older Patients with COVID 19: A New Index for Investigating Severity of Diseases

Arezoo Afkhami, Paniz Balmeh, Mahya Yargholi, Mahforouzalsadat Marashi, Zohreh Salehnassaj, Narges Ansari

Avicenna Journal of Aging and Healthcare · 29.08.2026 · 3 (1) · 7-13

DOI: 10.34172/ajah.4040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Avicenna Journal of Aging and Healthcare, online erschienen am 29.08.2026. Verfasst von Arezoo Afkhami und 5 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Coronavirus disease 2019 (COVID-19) can cause significant changes in serum biomarkers. C-reactive protein (CRP) and albumin (Alb) are proteins that can serve as potential markers of systemic inflammation. This study aimed to investigate CRP levels and the CRP/Alb ratio among hospitalized patients with COVID-19.

Methods

This cross-sectional analytical study was conducted among 114 patients with COVID-19 who were admitted to Al-Zahra Hospital in Isfahan, Iran, between 2021 and 2022. After checking the inclusion and exclusion criteria, demographic variables such as age, sex, and education level were collected, along with clinical data, including the number of days since symptom onset, length of hospitalization, initial oxygen saturation, severity of lung involvement, CRP, albumin, and the CRP/Alb ratio. Data were analyzed using SPSS version 20.

Results

The mean age of participants in this study was 60.36±16.37 years, with 63% being men. The mean first-day CRP level was 55.59±33.81. The mean CRP/Alb ratio in all patients was 17.31±11.60. In the group with severe lung involvement, the mean CRP/Alb ratio and Alb level were 22.99±11.27 and 3.14±0.46, respectively. Patients with severe lung involvement exhibited significant clinical and statistical differences in CRP/Alb ratio and albumin and CRP levels compared with those with mild or moderate lung involvement (P

Zitieren

APA

Afkhami, A., Balmeh, P., Yargholi, M., Marashi, M., Salehnassaj, Z., & Ansari, N. (2026). Evaluation of the Diagnostic Importance of Laboratory Markers in Older Patients with COVID 19: A New Index for Investigating Severity of Diseases. Avicenna Journal of Aging and Healthcare, 3(1), 7-13. https://doi.org/10.34172/ajah.4040

Vancouver

Afkhami A, Balmeh P, Yargholi M, Marashi M, Salehnassaj Z, Ansari N. Evaluation of the Diagnostic Importance of Laboratory Markers in Older Patients with COVID 19: A New Index for Investigating Severity of Diseases. Avicenna Journal of Aging and Healthcare. 2026;3(1):7-13. doi:10.34172/ajah.4040

BibTeX
@article{Afkhami2026,
  author = {Afkhami, Arezoo and Balmeh, Paniz and Yargholi, Mahya and Marashi, Mahforouzalsadat and Salehnassaj, Zohreh and Ansari, Narges},
  title = {Evaluation of the Diagnostic Importance of Laboratory Markers in Older Patients with COVID 19: A New Index for Investigating Severity of Diseases},
  journal = {Avicenna Journal of Aging and Healthcare},
  year = {2026},
  volume = {3},
  number = {1},
  pages = {7--13},
  doi = {10.34172/ajah.4040}
}
Kostenlos starten →